Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer
To evaluate the rate of complete pathological response after 3 cycles of gemcitabine containing chemotherapy.
Carcinoma, Non Small Cell Lung
DRUG: Gemcitabine|DRUG: Carboplatin|DRUG: Paclitaxel
Pathological complete response rate, in previously untreated patients with clinical Stage I and II non-small cell lung cancer (NSCLC).
Response rate, disease free survival,toxicities including pulmonary toxicity, operative mortality, and quality of life.
To evaluate the rate of complete pathological response after 3 cycles of gemcitabine containing chemotherapy.